Ormand Industries Inc
OMDD
Other OTC0.00
USD
- -
- -
ISIN
US6866791014
CUSIP
686679101
Return %
Stock
S&P500
1Y
0.00
17.85
3Y
- -
64.56
5Y
- -
69.89
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Nadav Kidron
- Full Time Employees
- 16
- Sector
- Healthcare
- Industry
- Medical - Specialties
- Address
- 13601 Preston Road Dallas TX United States of America 75240
- IPO Date
- Feb 24, 2015
- Website
- oramed.com
- Similar Companies
- Business
- Ormand Industries Inc engages in the manufacture, sale, refurbishment, and distribution of optical supplies. Its core product offerings include optical components and related equipment designed for various applications within the healthcare and industrial sectors. The company operates primarily in the United States, with headquarters located in Dallas, Texas. Founded several decades ago, Ormand Industries has established itself as a provider of specialized optical solutions. Recently, Ormand Industries has focused on expanding its product portfolio through strategic partnerships and enhanced manufacturing capabilities. The company has introduced new product lines targeting advanced optical applications and has increased its refurbishment services to support a broader range of optical instruments. Operationally, it has made significant steps to improve its supply chain efficiency and distribution network to better serve its market segments. As part of its growth strategy, Ormand continues to explore opportunities to expand its geographic footprint and product offerings, reinforcing its positioning in the health care and industrial optical supplies industry. Ormand Industries serves a diverse customer base including healthcare providers, research institutions, and industrial manufacturers who require precision optical components and services. The company continues to innovate in product development and service delivery to maintain competitive advantage within its sectors. It operates within the health care industry segment, focusing on technological enhancements and customer service improvements to meet evolving market demands.